Biopharmaceutical

Geron

$1.70
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.03 (-1.64%) As of 3:16 PM UTC today

Why Robinhood?

You can buy or sell Geron and other stocks, options, and ETFs commission-free!

About GERN

Geron Corp. operates as a biotechnology company. It develops a telomerase inhibitor, imetelstat, in hematologic myeloid malignancies. The firm develops therapeutic products for oncology. The company was founded by Michael D. West on November 28, 1990 and is headquartered in Menlo Park, CA. The listed name for GERN is Geron Corporation Common Stock.

CEO
John A. Scarlett
Employees
46
Headquarters
Foster City, California
Founded
1990
Market Cap
549.93M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
2.83M
High Today
$1.73
Low Today
$1.69
Open Price
$1.72
Volume
415.73K
52 Week High
$2.40
52 Week Low
$0.75

Collections

GERN Earnings

-$0.20
-$0.13
-$0.07
$0.00
Q2 FY19
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Estimated
— per share
Actual
Expected Mar 11, After Hours

You May Also Like

ARBGU
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure